CD8A and neoplasm: Our results demonstrate that TNBC-derived neoantigens can be recognized by the immune system, and that immunization of tumor-bearing mice with neoepitopes induced neoepitope-specific CD8+T cells, slowed tumor growth and increased survival of mice.